Abbott Claws Back More Glucose Monitoring IP On Appeal
A London appeals court restored two glucose monitoring patents on Monday that Abbott lost in its now-settled battle with Dexcom, adding to a third patent that the biotech business salvaged several...To view the full article, register now.
Already a subscriber? Click here to view full article